Tuan Nguyen

All filings by Tuan Nguyen on record concern Arbutus Biopharma Corp. The record holds 5 filings, for trades running from 2 February 2026 to 1 October 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 7 October 2026, reports a transaction of €212k in Arbutus Biopharma Corp. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.